Vijaya Diagnostic Centre Limited has informed the National Stock Exchange of India Limited and BSE Limited that a meeting of its Board of Directors is scheduled to be held on Thursday, May 07, 2026. The meeting has been convened pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for Board Meeting

The Board will consider and approve several key items during the meeting:

• The standalone and consolidated audited financial results of the company for the quarter and year ended March 31, 2026
• Recommend the dividend, if any, for the financial year ended March 31, 2026
• Other corporate matters

Trading Window Closure

As per the company's communication dated March 28, 2026, the trading window for dealing in the securities of Vijaya Diagnostic Centre Limited was closed for all designated persons and their immediate relatives from April 01, 2026. The window shall remain closed until 48 hours after the announcement of financial results, i.e., up to May 09, 2026 (both days inclusive).

Company Information

The intimation was signed by Ankit Shah, Chief Financial Officer of Vijaya Diagnostic Centre Limited, on April 30, 2026.

Vijaya Diagnostic Centre Limited has announced a postal ballot seeking shareholder approval for the appointment of two Independent Directors to strengthen its board governance. The company filed the notice with stock exchanges on April 09, 2026, outlining the proposed appointments and voting procedures.

Proposed Director Appointments

The postal ballot covers two special resolutions for Independent Director appointments:

Both directors were initially appointed as Additional Directors on February 13, 2026, subject to shareholder approval through this postal ballot process.

Voting Timeline and Process

The company has established a comprehensive timeline for the postal ballot process:

The company has engaged KFin Technologies Limited to provide remote e-voting facilities to shareholders. The postal ballot notice is being sent electronically to members whose email addresses are registered with the company or depository participants.

Director Profiles and Expertise

Mr. Ravi Shankararamiah brings over four decades of legal experience as a Senior Advocate with expertise in taxation, corporate and commercial laws, securities and capital markets, mergers and acquisitions, and dispute resolution. He holds degrees from Bangalore University and the University of Southern California, graduating magna cum laude.

Dr. Sasikala Paruchuri Kola contributes over three decades of healthcare experience as a senior Consultant Gynaecologist and Obstetrician. She holds an MD and DGO from Osmania Medical College and has held key leadership positions in professional bodies including the Federation of Obstetric and Gynaecological Societies of India.

Regulatory Compliance

The appointments comply with provisions of the Companies Act, 2013, and SEBI Listing Regulations. Both directors have submitted required statutory disclosures, including:

• Consent to act as directors in Form DIR-2
• Declarations confirming independence criteria
• Confirmations of non-disqualification under Section 164(2)
• Registration in the Independent Directors' Databank

The Board of Directors has recommended both special resolutions for shareholder approval, emphasizing the directors' relevant expertise and potential contributions to the company's governance and strategic decision-making processes.